Nasdaq:NHTC
NATURAL HEALTH TRENDS CORP
A Nasdaq-listed developer of proprietary natural health products targeting the growing organic supplement market with a diversified retail footprint.
Key Metrics
Investment Thesis
Bull Case
Despite recent financial headwinds, NHTC possesses a robust pipeline of R&D investments targeting emerging wellness trends like adaptogens and gut health which could drive future revenue recovery. The company's strong brand equity and direct consumer relationships provide a defensive moat against economic downturns that often impacts discretionary spending less severely than other sectors. If the new product launches gain traction, the company is well-positioned to reverse its current negative growth trajectory.
Bear Case
The stock presents significant risk given the consistent year-over-year revenue decline and the transition from profit to a substantial net loss over the last two years. Investors should be wary of the company's reliance on mark-to-market adjustments in marketable securities which may not reflect realizable value if liquidity needs arise. The negative operating cash flow combined with a shrinking cash balance suggests the business model is currently burning capital without generating sufficient returns.
About NATURAL HEALTH TRENDS CORP
Natural Health Trends Corp specializes in the development and commercialization of proprietary natural health products, targeting consumers seeking organic supplements and wellness solutions. The company generates revenue through direct-to-consumer sales and strategic partnerships with major retail chains across North America. With a focus on innovation in botanical extracts and nutritional formulas, NHTC aims to capture market share in the expanding global wellness sector.
Analysis
Management Discussion
Management's recent financial performance shows a concerning trend of declining revenue from $49.1M in 2022 down to $39.8M in 2025, coinciding with a shift from profitability to an $882k net loss. The significant reduction in cash reserves and substantial dividends paid despite negative earnings suggest potential capital allocation challenges or aggressive shareholder return strategies that may not be sustainable given the deteriorating operational metrics.
Industry Overview
The natural health and wellness industry is experiencing rapid expansion driven by shifting consumer preferences toward organic, plant-based, and scientifically backed supplements. However, the sector faces increasing regulatory scrutiny regarding labeling claims and ingredient sourcing which can impact smaller players more severely than large incumbents. Market consolidation is expected as companies with sustainable unit economics outpace those struggling with margin compression and inventory inefficiencies.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $49.1M | $43.9M | $43.0M | $39.8M |
| Cost of Revenue | $12.7M | $11.2M | $11.2M | $10.5M |
| Gross Profit | $36.5M | $32.7M | $31.8M | $29.3M |
| Operating Expenses | $36.7M | $34.4M | $33.1M | $31.1M |
| Operating Income | $-270.0K | $-1.7M | $-1.3M | $-1.8M |
| G&A | $16.0M | $16.0M | $15.5M | $14.8M |
| Stock-Based Comp | — | $161.0K | $145.0K | $132.0K |
| D&A | $204.0K | $164.0K | $131.0K | $109.0K |
| Other OpEx | $20.7M | $18.4M | $17.6M | $16.3M |
| Non-Operating Income | $872.0K | $2.4M | $1.9M | $1.2M |
| Pre-Tax Income | $602.0K | $745.0K | $620.0K | $-567.0K |
| Income Tax | $289.0K | $177.0K | $48.0K | $315.0K |
| Continuing Ops | $313.0K | $568.0K | $572.0K | $-882.0K |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $313.0K | $568.0K | $572.0K | $-882.0K |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $313.0K | $568.0K | $572.0K | $-882.0K |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $77.6M | $64.2M | $51.0M | $34.2M |
| Cash & Equivalents | $69.7M | $56.2M | $13.5M | $6.8M |
| Marketable Securities | — | — | $30.4M | $22.1M |
| Inventory | $4.5M | $4.3M | $3.3M | $2.0M |
| Other Current Assets | $3.4M | $3.8M | $3.8M | $3.3M |
| Long-Term Assets | $5.3M | $4.9M | $4.4M | $4.2M |
| PP&E (Net) | $394.0K | $266.0K | $190.0K | $153.0K |
| Operating Leases | $4.0M | $3.3M | $2.5M | $1.9M |
| Other LT Assets | $880.0K | $1.3M | $1.7M | $2.2M |
| Total Assets | $82.8M | $69.1M | $55.4M | $38.4M |
| Current Liabilities | $20.4M | $20.0M | $20.8M | $13.7M |
| Accounts Payable | $810.0K | $990.0K | $895.0K | $555.0K |
| Current Leases | $1.1M | $1.1M | $1.1M | $869.0K |
| Deferred Revenue | $5.6M | $6.2M | $6.4M | $5.6M |
| Taxes Payable | $3.0M | $3.7M | $4.9M | $5.0K |
| Other Current Liab | $8.7M | $6.8M | $6.0M | $5.2M |
| Long-Term Liabilities | $12.2M | $7.5M | $1.7M | $1.3M |
| LT Operating Leases | $3.0M | $2.3M | $1.5M | $1.1M |
| Other LT Liab | $141.0K | $135.0K | $174.0K | $180.0K |
| Total Liabilities | $32.7M | $27.5M | $22.5M | $15.0M |
| Shareholders' Equity | $50.2M | $41.6M | $32.9M | $23.4M |
| Paid-In Capital | $86.1M | $84.7M | $84.9M | $85.0M |
| Retained Earnings | $-9.1M | $-17.7M | $-26.3M | $-36.4M |
| AOCI | $-1.0M | $-1.1M | $-1.3M | $-784.0K |
| Treasury Stock | $25.9M | — | — | — |
| Total L&E | $82.8M | $69.1M | $55.4M | $38.4M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $313.0K | $568.0K | $572.0K | $-882.0K |
| Non-Cash Adjustments | $5.2M | $-7.1M | $-4.9M | $-974.0K |
| Working Capital Changes | $-10.3M | $2.2M | $932.0K | $-4.1M |
| Cash from Operations | $-4.9M | $-4.3M | $-3.4M | $-6.0M |
| Capital Expenditures | $143.0K | $46.0K | $57.0K | $68.0K |
| Cash from Investing | $-143.0K | $-46.0K | $-30.1M | $8.1M |
| Dividends Paid | $9.1M | $9.2M | $9.2M | $9.2M |
| Cash from Financing | $-9.1M | $-9.2M | $-9.2M | $-9.2M |
| FX Effect | $-486.0K | $10.0K | $5.0K | $312.0K |
| Net Change in Cash | $-14.6M | $-13.5M | $-42.6M | $-6.7M |
| Beginning Cash | $84.4M | $69.7M | $56.2M | $13.6M |
| Ending Cash | $69.7M | $56.2M | $13.6M | $6.8M |
Frequently Asked Questions
How does NATURAL HEALTH TRENDS CORP make money?
The company's revenue is primarily derived from direct-to-consumer sales via its e-commerce platform, distribution through major North American retail partners, and licensing agreements for exclusive botanical formulations to third-party manufacturers. A smaller segment includes strategic partnerships with international wellness brands that provide recurring royalty income based on product performance.
What are the main risks for NHTC?
Recent consecutive years of declining revenue and net income losses indicate potential issues with demand saturation or pricing power erosion that investors must monitor closely. The company faces significant cash flow constraints, evidenced by negative operating cash flows and a growing retained earnings deficit, which limits its ability to fund growth without external financing. Intense competition from larger pharmaceutical giants and private label manufacturers could further compress margins in the natural health sector.
What is NHTC's competitive advantage?
NHTC leverages a proprietary portfolio of patented natural extracts that offer unique health benefits not easily replicated by generic competitors. The company maintains a strong brand reputation built on transparency and clinical validation of its products, fostering high customer loyalty in the crowded supplement market. Its vertically integrated supply chain for organic ingredients provides cost control advantages and ensures consistent product quality amidst industry volatility.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.